1. Home
  2. ELTK vs ANVS Comparison

ELTK vs ANVS Comparison

Compare ELTK & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$6.80

Market Cap

53.8M

Sector

Technology

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$0.99

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
ANVS
Founded
1970
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.8M
50.4M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
ELTK
ANVS
Price
$6.80
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
2.8K
★ 766.0K
Earning Date
11-17-2026
11-11-2026
Dividend Yield
★ 2.80%
N/A
EPS Growth
N/A
★ 39.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.79
$1.01
52 Week High
$11.59
$5.50

Technical Indicators

Market Signals
Indicator
ELTK
ANVS
Relative Strength Index (RSI) 30.29 32.33
Support Level N/A N/A
Resistance Level $9.69 $1.43
Average True Range (ATR) 0.19 0.08
MACD -0.12 -0.01
Stochastic Oscillator 5.45 1.22

Price Performance

Historical Comparison
ELTK
ANVS

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: